The Women's Screening and Self-Testing Program (PROMETA) Study
Recruiting
N/A
Interventional Study
Human Papilloma Virus Related Cervical Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 25 – 49
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 8,445 (estimated)
- Sponsor
- Tulane University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-posi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women 25-49 years
* Accessing HIV care and treatment services
* Not being pregnant
* Patients with a cervix
Exclusion Criteria:
* Physical or mental impairment that inhibits participation in the study
* Pregnant women or \<6 weeks post-partum
* Women who have undergone a tot…
Contacts